The Intelligence from The Economist cover image

Hot shot: the wider promise of weight-loss jabs

The Intelligence from The Economist

CHAPTER

The Promise of GLP-1 Receptor Agonists

This chapter explores the transformative effects of GLP-1 receptor agonists, new weight-loss drugs initially developed for diabetes that may also improve heart health and other conditions. It highlights the ongoing research and broader potential applications of these medications, likening them to a 'Swiss army knife' for various health issues.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner